Van Guilder Gary P, Hoetzer Greta L, Greiner Jared J, Stauffer Brian L, DeSouza Christopher A
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, 354 UCB, Boulder, CO 80309, USA.
J Physiol. 2008 Jul 15;586(14):3525-35. doi: 10.1113/jphysiol.2008.151555. Epub 2008 May 22.
We determined the effects of acute intra-arterial vitamin C administration and chronic oral vitamin C supplementation on the capacity of the endothelium to release t-PA in overweight and obese adults. Net endothelial t-PA release was determined in vivo in response to intrabrachial infusions of bradykinin and sodium nitroprusside in 33 sedentary adults: 10 normal-weight (BMI: 23.4 +/- 0.5 kg m(-2); 7M/3F); and 23 overweight/obese (BMI: 31.2 +/- 0.8 kg m(-2); 15M/8F). In 10 normal weight and eight overweight/obese adults the dose-response curves to bradykinin and sodium nitroprusside were repeated with a coinfusion of the antioxidant vitamin C (24 mg min(-1)). Seventeen of the 23 overweight/obese adults completed a 3 month chronic oral vitamin C (500 mg day(-1)) supplementation intervention. Intra-arterial administration of vitamin C significantly potentiated t-PA release in overweight/obese adults. Net release of t-PA was approximately 95% higher (P < 0.01) after (from -0.9 +/- 1.1 to 94.6 +/- 16.2 ng (100 ml tissue)(-1) min(-1)) compared with before (from -0.8 +/- 0.8 to 49.9 +/- 7.7 ng (100 ml tissue)(-1) min(-1)) vitamin C administration. Daily vitamin C supplementation significantly increased t-PA release in overweight/obese adults (from 0.2 +/- 0.9 to 48.2 +/- 6.5 ng (100 ml tissue)(-1) min(-1)) before supplementation versus (0.3 +/- 0.5 to 66.3 +/- 8.7 ng (100 ml tissue)(-1) min(-1)) after supplementation. These results indicate that the antioxidant vitamin C favourably affects the capacity of the endothelium to release t-PA in overweight/obese adults. Daily vitamin C supplementation represents an effective lifestyle intervention strategy for improving endothelial fibrinolytic regulation in this at-risk population.
我们测定了急性动脉内给予维生素C和慢性口服补充维生素C对超重及肥胖成年人内皮细胞释放组织型纤溶酶原激活剂(t-PA)能力的影响。在33名久坐不动的成年人中,通过肱动脉内输注缓激肽和硝普钠,在体内测定内皮细胞t-PA的净释放量:10名体重正常者(体重指数:23.4±0.5kg/m²;7名男性/3名女性);以及23名超重/肥胖者(体重指数:31.2±0.8kg/m²;15名男性/8名女性)。在10名体重正常和8名超重/肥胖成年人中,在输注抗氧化剂维生素C(24mg/min)的同时重复测定对缓激肽和硝普钠的剂量反应曲线。23名超重/肥胖成年人中有17名完成了为期3个月的慢性口服维生素C(500mg/天)补充干预。动脉内给予维生素C显著增强了超重/肥胖成年人t-PA的释放。与给予维生素C之前(从-0.8±0.8至49.9±7.7ng/(100ml组织)⁻¹min⁻¹)相比,给予维生素C后t-PA的净释放量高出约95%(P<0.01)(从-0.9±1.1至94.6±16.2ng/(100ml组织)⁻¹min⁻¹)。每日补充维生素C显著增加了超重/肥胖成年人t-PA的释放(补充前从0.2±0.9至48.2±6.5ng/(100ml组织)⁻¹min⁻¹,补充后从0.3±0.5至66.3±8.7ng/(100ml组织)⁻¹min⁻¹)。这些结果表明,抗氧化剂维生素C对超重/肥胖成年人内皮细胞释放t-PA的能力有有利影响。每日补充维生素C是改善这一高危人群内皮纤维蛋白溶解调节的有效生活方式干预策略。